Home
/
Rallybio Corp
/
Financials
/
Quarterly
Rallybio Corp — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Rallybio Corp filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$212.0K
Nov 6, 2025
Q2
2025
Jun 30, 2025
$212.0K
Aug 7, 2025
Q1
2025
Mar 31, 2025
$212.0K
May 8, 2025
Q3
2025
Sep 30, 2024
$299.0K
Nov 6, 2025
Q2
2025
Jun 30, 2024
$299.0K
Aug 7, 2025
Q1
2025
Mar 31, 2024
$0
May 8, 2025
Q3
2024
Sep 30, 2023
$0
Nov 7, 2024
Q2
2024
Jun 30, 2023
$0
Aug 8, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$16.02M
Nov 6, 2025
Q2
2025
Jun 30, 2025
($9.70M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($9.44M)
May 8, 2025
Q3
2025
Sep 30, 2024
($11.47M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($16.24M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($19.03M)
May 8, 2025
Q3
2024
Sep 30, 2023
($18.37M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($18.63M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($17.32M)
May 9, 2024
Q3
2023
Sep 30, 2022
($18.37M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($17.58M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($14.50M)
May 9, 2023
Q3
2022
Sep 30, 2021
($10.20M)
Nov 7, 2022
Q2
2022
Jun 30, 2021
($11.13M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($13.28M)
May 10, 2022
Q3
2021
Sep 30, 2020
($7.16M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($4.89M)
Sep 9, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($6.93M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($10.06M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($9.67M)
May 8, 2025
Q3
2025
Sep 30, 2024
($12.07M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($17.04M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($19.79M)
May 8, 2025
Q3
2024
Sep 30, 2023
($19.36M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($20.08M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($18.37M)
May 9, 2024
Q3
2023
Sep 30, 2022
($18.86M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($17.62M)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($14.32M)
May 9, 2023
Q3
2022
Sep 30, 2021
($9.98M)
Nov 7, 2022
Q2
2022
Jun 30, 2021
($10.53M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($12.82M)
May 10, 2022
Q3
2021
Sep 30, 2020
($6.71M)
Nov 10, 2021
Q2
2021
Jun 30, 2020
($4.66M)
Sep 9, 2021